| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/07/2009 | WO2009029888A3 Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity |
| 05/07/2009 | WO2009029866A3 Minimizing trauma during and after insertion of a cochlear lead |
| 05/07/2009 | WO2009027786A3 Matrix dosage forms of varenicline |
| 05/07/2009 | WO2009016536A3 Preservative compositions for moist wipes |
| 05/07/2009 | WO2009010303A3 System for administering active substances to an organism, devices for use in said type of system and method for producing said type of devices |
| 05/07/2009 | WO2009007409A3 Oil in water emulsion comprising nsaids and quaternary ammonium halides |
| 05/07/2009 | WO2008134013A3 Pharmaceutical excipient complex |
| 05/07/2009 | WO2008133982A3 Adhesive patch with aversive agent |
| 05/07/2009 | WO2008129517A3 A stabilized delayed release pharmaceutical composition of rabeprazole |
| 05/07/2009 | WO2008118960A3 Radiation protection using carbon nanotube derivatives |
| 05/07/2009 | WO2008106979A3 Pharmaceutical compositions comprising flavonoids and xylitol |
| 05/07/2009 | WO2008098019A3 Polymer formulations for delivery of bioactive agents |
| 05/07/2009 | WO2008065660A3 Oxygen supply for cell transplant and vascularization |
| 05/07/2009 | WO2008060786A3 Microencapsules containing surface-modified microparticles and methods of forming and using the same |
| 05/07/2009 | WO2008053484A3 Preparation of heavy metal-containing nano-liposomes and their uses in medical therapy |
| 05/07/2009 | WO2008046541A3 Film-forming gel composition for wound or skin care |
| 05/07/2009 | WO2008039193A3 Method and system for treatment of eating disorders |
| 05/07/2009 | WO2008039052A8 Process for stabilizing famotidine |
| 05/07/2009 | WO2007092253A3 Induced-charge electro-osmotic microfluidic devices |
| 05/07/2009 | WO2007080509A3 Sustained release compositions of alfuzosin |
| 05/07/2009 | WO2007056473A3 Acoustically controlled reaction device |
| 05/07/2009 | WO2007018943A3 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/07/2009 | WO2006102052A3 Method and composition for neutralizing odors |
| 05/07/2009 | WO2006086330A3 Pharmaceutical compositions |
| 05/07/2009 | WO2006028996A3 Emulsan-alginate microspheres and methods of use thereof |
| 05/07/2009 | WO2006020727A3 Methods for treating cns disorders by administration of agents to the nasal cavity |
| 05/07/2009 | US20090118711 Reduced-noise implantable infusion device |
| 05/07/2009 | US20090118710 Non-invasive analysis and controlled dosage transdermal active patch |
| 05/07/2009 | US20090118579 Medical capsule |
| 05/07/2009 | US20090118256 Chronotherapeutic diltiazem formulations and the administration thereof |
| 05/07/2009 | US20090118252 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 05/07/2009 | US20090118251 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 05/07/2009 | US20090118250 Pharmaceutical composition |
| 05/07/2009 | US20090118247 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
| 05/07/2009 | US20090118246 Therapeutic ophthalmic compositions containing retinal friendly recpients and related methods |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | US20090118170 Buccal, polar and non-polar spray or capsule |
| 05/07/2009 | US20090118158 peptide YY, Neuropeptide Y, or Pancreatic polypeptide with solubilizing agent (cyclodextran), chelating agent (ethylenediamine tetraacetic acid), pH control agent (arginine, sodium hydroxide, glycine, hydrochloric acid) and preservatives ( methylparaben or propylparaben); eating disorder |
| 05/07/2009 | US20090117196 A method for embolization by administering crosslinked polyvinylalcohol microspheres substantially spherical, sterile, and having any excess aldehyde on surfaces neutralized by an aminoalcohol; antitumor agents; hemostatic agents; analgesics; surgery; biocompatability; nontoxic; antiagglomerants |
| 05/07/2009 | US20090117195 Hydrophilic Particles Based on Cationic Chitosan Derivatives |
| 05/07/2009 | US20090117194 Eukaryotic microorganisms for producing lipids and antioxidants |
| 05/07/2009 | US20090117193 Compositions Comprising an Active Agent |
| 05/07/2009 | US20090117192 Composition for transdermal absorption and formulation comprising a polymeric matrix formed therefrom |
| 05/07/2009 | US20090117191 Controlled release tramadol formulations |
| 05/07/2009 | US20090117190 Sustained-release preparation |
| 05/07/2009 | US20090117189 Method for the Production of Polymerized Nanoparticles and Microparticles by Ternary Agent Concentration and Temperature Alteration Induced Immiscibility |
| 05/07/2009 | US20090117188 Methods of Augmenting or Repairing Soft Tissue |
| 05/07/2009 | US20090117187 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 05/07/2009 | US20090117186 Trofosfamide-containing film-coated tablets and method for the production thereof |
| 05/07/2009 | US20090117185 2-(Aminomethyl)-5-Chlorobenzylamide Derivatives and their use as Inhibitors of the Clotting Factor Xa |
| 05/07/2009 | US20090117184 Use of a gestagen in combination with an estrogen and one or more pharmaceutically acceptable auxiliary agents/excipients for lactose-free oral contraception |
| 05/07/2009 | US20090117183 Oral contraceptive containing a gestagen and an estrogen combined with pharmaceutically acceptable auxiliary agents and/or excipients, but not containing lactose, and method of making same |
| 05/07/2009 | US20090117182 Intraorally rapidly disintegrating tablet |
| 05/07/2009 | US20090117181 Tablet comprising fluvastatin and carmellose calcium |
| 05/07/2009 | US20090117180 Stable digestive enzyme compositions |
| 05/07/2009 | US20090117179 siDNA against Influenza Virus |
| 05/07/2009 | US20090117178 with immunogenic or therapeutic properties against ischemic cardiovascular diseases; atherosclerosis |
| 05/07/2009 | US20090117177 Echogenic microbubbles and microemulsions for ultrasound-enhanced nanoparticle-mediated delivery of agents |
| 05/07/2009 | US20090117176 Anticancer Treatments |
| 05/07/2009 | US20090117174 Modified sorbitan siloxane compositions and use thereof |
| 05/07/2009 | US20090117173 Antimicrobial glaze and poreclain enamel via double layer glaze with high zinc content |
| 05/07/2009 | US20090117172 Oral delivery vehicle and material |
| 05/07/2009 | US20090117171 Compositions and methods for treatment of macular degeneration and related conditions |
| 05/07/2009 | US20090117170 Segmented device for the delayed release of molecules in a tangential direction through thin films and uses thereof |
| 05/07/2009 | US20090117169 Methods and compositions for regulating proliferation and migration of vascular smooth muscle cells |
| 05/07/2009 | US20090117167 Injectable capsaicin with vasocontrictor adjunctive agent |
| 05/07/2009 | US20090117166 Sequential coupling of biomolecule layers to polymers |
| 05/07/2009 | US20090117163 Composition and Method for the Application of Human Synthetic Pheromones Using Substance Slowly Releasing Technological Bio Capsule in form of Drops in Clothing, Underwear, Jewels and Like |
| 05/07/2009 | US20090117159 Pharmaceutical compositions comprising fesoterodine |
| 05/07/2009 | US20090117158 Transdermal sustained release drug delivery |
| 05/07/2009 | US20090117075 Temperature Responsive Delivery Systems |
| 05/07/2009 | US20090117072 Treatment of periodontal disease |
| 05/07/2009 | US20090117056 Probiotic oral dosage forms |
| 05/07/2009 | US20090117054 Sublingual spray for the treatment of pain |
| 05/07/2009 | US20090117045 Soy or lentil stabilized gold nanoparticles and method for making same |
| 05/07/2009 | US20090117039 Charged biodegradable polymers for medical applications |
| 05/07/2009 | US20090117035 Temperature-Sensitive Liposomal Formulation |
| 05/07/2009 | US20090117033 Injectable biodegradable particles |
| 05/07/2009 | DE4042752B4 Verfahren zur Herstellung von Mikropartikeln, welche einen Wirkstoff in einem bioabbaubaren polymeren Träger enthalten Process for the preparation of microparticles containing an active agent in a biodegradable polymeric carrier, |
| 05/07/2009 | DE102007052871A1 Kapsel zur Aufnahme von pharmazeutischen Wirkstoffformulierungen Capsule for holding pharmaceutical drug formulations |
| 05/07/2009 | DE102007052071A1 Stabilisiertes Atorvastatin Stabilized atorvastatin |
| 05/07/2009 | DE102007052070A1 Candesartancilexetil Candesartancilexetil |
| 05/07/2009 | DE102007051914A1 Verfahren zur Herstellung von mit Wachstumsfaktoren beladenen Partikeln sowie die so erhaltenen Partikel A process for preparing loaded with growth factors, as well as particles, the particles thus obtained |
| 05/07/2009 | DE10010113B4 Natives Schwammkollagen, Verfahren zu seiner Isolierung und seine Verwendung, sowie natives nanopartikuläres Schwammkollagen, Verfahren zu seiner Herstellung und seine Verwendung Native collagen sponge, process for its isolation and its use, as well as native nanoparticulate sponge collagen, process for its preparation and its use |
| 05/07/2009 | CA2739011A1 Osteoarthritis gene therapy |
| 05/07/2009 | CA2704430A1 Injectable meclizine formulations and methods |
| 05/07/2009 | CA2704262A1 Ingestible film composition |
| 05/07/2009 | CA2704209A1 Orally disintegrated dosage form |
| 05/07/2009 | CA2704117A1 Transdermal delivery system |
| 05/07/2009 | CA2704116A1 Transdermal delivery system for hormones and steroids |
| 05/07/2009 | CA2704102A1 Improved tablet coating |
| 05/07/2009 | CA2704056A1 Encapsulated nanoparticles for nucleic acid delivery |
| 05/07/2009 | CA2703971A1 Stabilized pediatric suspension of carisbamate |
| 05/07/2009 | CA2703918A1 Novel antiretroviral combination |
| 05/07/2009 | CA2703816A1 Composition comprising polyunsaturated fatty acids and activated charcoal |
| 05/07/2009 | CA2703063A1 Compositions for treating parkinson's disease |
| 05/07/2009 | CA2702761A1 Non-aqueous water-miscible materials as vehicles for drug delivery |
| 05/07/2009 | CA2701703A1 Topical composition |
| 05/07/2009 | CA2700662A1 Lh liquid formulations |
| 05/07/2009 | CA2699588A1 Bupropion hydrobromide and therapeutic applications |